Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial
(2019)
Journal Article
Zaman, A., de Winter, R. J., Kogame, N., Chang, C. C., Modolo, R., Spitzer, E., Tonino, P., Hofma, S., Zurakowski, A., Smits, P. C., Prokopczuk, J., Moreno, R., Choudhury, A., Petrov, I., Cequier, A., Kukreja, N., Hoye, A., Iniguez, A., Ungi, I., Serra, A., …Serruys, P. W. (2019). Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial. Lancet, 393(10175), 987-997. https://doi.org/10.1016/S0140-6736%2818%2932467-X
Background: Supraflex is a sirolimus-eluting stent with a biodegradable polymer coating and ultra-thin struts. We aimed to compare Supraflex with the standard of care, Xience, an everolimus-eluting stent with a durable polymer coating, regarding clin...
Read More about Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial.